📰 Practice Management News
Page 57 - Practice Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Management. Real-time updates on events, politics, business and more.
September 25, 2023
A special master overseeing opioid litigation is resisting a request to step down after he mistakenly sent lawyers a “reply all” email with private notes to himself.
September 22, 2023
Advanced practice providers are handling more primary care visits and seeing more patients, particularly for conditions such as respiratory infections and anxiety, according to recent research.
September 22, 2023
Legal technology CEO Kiwi Camara’s resignation last week has been followed by a new report suggesting that the executive allegedly groped a young female employee at a company dinner.
September 22, 2023
Pillsbury Winthrop Shaw Pittman confirmed Thursday that it is discussing a possible merger with Stroock & Stroock & Lavan after the latter law firm failed to reach a merger deal with Nixon Peabody.
September 22, 2023
FTX founder Sam Bankman-Fried has alleged that Sullivan & Cromwell lawyers made him the fall guy in the collapse of the cryptocurrency exchange while downplaying its work for the company.
September 21, 2023
The US neurologist shortage is reducing patients access to care and increasing physician burnout, siphoning off members of a critical workforce that isnt growing fast enough.
September 21, 2023
High-profile lawyer David Boies charges $2,110 per hour, putting him “in a still-rarified realm of attorneys who charge upwards of $2,000 an hour,” according to Reuters.
September 21, 2023
US employers are bracing for the largest increase in health insurance costs in a decade next year, according forecasts from healthcare consultants.
September 21, 2023
The Joint Commission next year will start a voluntary program to help hospitals reduce their greenhouse gas emissions after dropping a proposal to require emissions reporting for accreditation.
September 20, 2023
The initiative will ensure the availability of a drug that otherwise would have been abandoned as unprofitable.